Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2014
05/07/2014CN102899343B 一种基因载体系统及其制备和应用 Of a gene vector system and its preparation and application
05/07/2014CN102895485B 一种治疗围绝经期肾虚血瘀的中药组合物及其制备方法 A method of treating perimenopausal Kidney Blood Chinese medicine composition and its preparation method
05/07/2014CN102872212B 肝脏x受体激动剂的筛选方法 The screening method of the liver x receptor agonists
05/07/2014CN102872185B 一种超声提取紫花苜蓿中香豆素的方法 An ultrasonic extraction method alfalfa coumarin
05/07/2014CN102827875B 表达小鼠神经生长因子的重组腺病毒及其制备方法 Expression of mouse nerve growth factor recombinant adenovirus and its preparation method
05/07/2014CN102776129B 一株头棒束孢霉及其应用 A head bundle Neurospora crassa and Its Application
05/07/2014CN102743598B 一种叠鞘石斛提取物及其配方颗粒 An iterative sheath extracts and formulations particles Dendrobium
05/07/2014CN102702155B 基于体内代谢机制的灯盏乙素苷元甲基化产物及其制备方法和其应用 Based on in vivo metabolic mechanisms scutellarin aglycone methylated product and its preparation method and its application
05/07/2014CN102670485B 含缬沙坦的固体组合物中水解杂质h的研究及控制方法 Research and control method of valsartan solid composition containing hydrolyzed impurities h
05/07/2014CN102641393B 一种用于治疗中风的中药组合物 Chinese medicine composition for treating stroke
05/07/2014CN102626396B 一种美托洛尔缓释片剂及其制备方法 One kind of metoprolol extended-release tablets and its preparation method
05/07/2014CN102552633B 一种药物组合物 A pharmaceutical composition
05/07/2014CN102552394B 一种复方丹参片的制备方法 A method for preparing Compound Salvia Tablets
05/07/2014CN102532345B 一类o-不饱和脂肪酸酰化壳寡糖及其制备和应用 A class of o- unsaturated fatty acylated chitosan oligosaccharide and its preparation and application
05/07/2014CN102462695B 亚硫酸钠的新用途 New use of sodium sulfite
05/07/2014CN102416036B 一种防治冠心病心室重构的中药组合物及其应用 A coronary heart ventricular remodeling composition and application of traditional Chinese medicine Prevention
05/07/2014CN102367257B 氯吡格雷盐酸盐的单晶晶型,它们的制备及应用 Clopidogrel hydrochloride single crystal type, their preparation and application
05/07/2014CN102258623B 一种用于治疗冠心病心功能不全的组分中药及其制备方法 Component of traditional Chinese medicine and its preparation method for the treatment of coronary heart disease heart failure
05/07/2014CN102240388B 一种姜提取物、其制备方法及其用途 One kind of ginger extract, their preparation and their use
05/07/2014CN102219748B 无定型安贝生坦及其制备方法 Amorphous ambrisentan and its preparation method
05/07/2014CN102164918B 固体药物组合物 The solid pharmaceutical composition
05/07/2014CN102159582B 作为Edg-1受体激动剂的噁唑并嘧啶 Edg-1 receptor agonists as oxazole pyrimidine
05/07/2014CN101993389B D(+)β-(3,4-二羟基苯基)-α-羟基丙酰肼、制备方法及其药物组合物和用途 D (+) β- (3,4- dihydroxyphenyl) -α- hydroxy-propionyl hydrazide, preparation and pharmaceutical compositions and uses
05/07/2014CN101747440B 一种TNFR-Fc融合蛋白及其用途 One kind of TNFR-Fc fusion proteins and their use
05/07/2014CN101686959B 作为血小板adp受体抑制剂的化合物的组合疗法 Combination therapy as inhibitors of platelet adp receptor compound
05/07/2014CN101678013B 哌啶/哌嗪衍生物 Piperidine / piperazine derivatives
05/06/2014US8716493 Multicyclic compounds and the use thereof
05/06/2014US8716445 Compositions comprising signal peptide-containing proteins
05/06/2014US8716323 Cyclic protein tyrosine kinase inhibitors
05/06/2014US8716321 Methods for dosing an orally active 1,2,4-oxadiazole
05/06/2014US8716315 Analogs of thalidomide as potential angiogenesis inhibitors
05/06/2014US8716312 Inhibitors of diacylglycerol acyltransferase
05/06/2014US8716251 Pharmaceutical formulations containing an SGLT2 inhibitor
05/06/2014US8716249 Compositions and methods for improving cardiovascular health
05/06/2014US8715968 Methods and reagents for modulating cholesterol levels
05/06/2014US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof
05/06/2014US8715341 Drug-delivery endovascular stent and method of forming the same
05/06/2014CA2744985C Carboxylic acid derivative containing thiazole ring useful for the prevention or treatment of hyperlipidemia
05/06/2014CA2666371C Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition
05/06/2014CA2628305C Jelly composition
05/06/2014CA2617378C Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
05/01/2014WO2014066743A1 Heterocyclic compounds for the inhibition of pask
05/01/2014WO2014066695A1 Compositions and methods for treating estrogen-related medical disorders
05/01/2014WO2014066442A2 Methods of managing childhood cerebral injury
05/01/2014WO2014066058A1 Dual variable domain (dvd) immunoglobulins for reducing major adverse cardiovascular events (mace) in diabetic patients subsequent to stent placement
05/01/2014WO2014065575A1 4,5-dihydro-1h-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
05/01/2014WO2014065370A1 Pulmonary hypertension therapeutic agent
05/01/2014WO2014065347A1 Novel method for treating cardiac infarction using hmgb1 fragment
05/01/2014WO2014065270A1 Tetrahydrooxazolo-pyridine derivative
05/01/2014WO2014065017A1 Artificial blood vessel, and method for producing artificial blood vessel
05/01/2014WO2014064811A1 Pulmonary hypertension therapeutic agent
05/01/2014WO2014064630A1 Pharmaceutical composition for reducing the trimethylamine n-oxide level
05/01/2014WO2014064292A1 A method for preventing or treating atrial fibrillation
05/01/2014WO2014064077A1 Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine
05/01/2014WO2014063312A1 Use of salvianolic acid a in prevention and/or treatment of cerebral microvascular thromboembolic disease
05/01/2014WO2014063239A1 Peptides and methods for preventing ischemic tissue injury
05/01/2014WO2014063190A1 Method for reducing triglycerides
05/01/2014WO2014063189A1 Methods and products for preventing and/or treating a stress induced cardiomyopathy
05/01/2014WO2014037834A3 Compositions and methods for treatment of inflammation and lipid disorders
05/01/2014WO2012135465A3 Treatment of glaucoma
05/01/2014US20140121283 Methods of using derivatives of (-)-venlafaxine
05/01/2014US20140121228 Quinazoline Derivatives as VEGF Inhibitors
04/2014
04/30/2014EP2725024A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use
04/30/2014EP2723853A1 In vitro cardiovascular model
04/30/2014EP2723364A1 Cell secreted proteins for the treatment of myocardial infarction
04/30/2014EP2723363A2 Combination therapy for ischemia
04/30/2014EP2723333A1 Treatment and prevention of diseases related to oxidative stress
04/30/2014CN103764621A Epoxyeicosatrienoic acid analogs and methods of making and using the same
04/30/2014CN103764146A Nicorandil-containing pharmaceutical composition
04/30/2014CN103764126A Pharmaceutical composition and solid galenic form having a high dronedarone content, and method for preparing same
04/30/2014CN103756849A Heat-clearing and detoxifying health care wine
04/30/2014CN103756828A Blood pressure lowering grape wine and preparation method thereof
04/30/2014CN103755808A Novel anti-alpha5beta1 antibodies and uses thereof
04/30/2014CN103755786A Melanocortin receptor ligands
04/30/2014CN103755783A Dipeptide QD with double functions of lowering blood pressure and lowering blood fat and application thereof
04/30/2014CN103755782A Dipeptide ST with double functions of lowering blood pressure and lowering blood fat and application thereof
04/30/2014CN103755781A Dipeptide GD with double functions of reducing blood pressure and blood fat and purposes thereof
04/30/2014CN103755768A CDDO ethyl ester polymorphic substance and application thereof
04/30/2014CN103755767A CDDO ethyl ester polymorphic substance and application thereof
04/30/2014CN103755714A Phthalocyanine-hydrotalcite complex and preparation method and application thereof
04/30/2014CN103755713A Octa-sulfonic phthalocyanine, and preparation method and application thereof
04/30/2014CN103755694A Treatment method of azilsartan crude drug
04/30/2014CN103755687A Hydrochloric tandospirone crystal form I and preparation method of crystal form I
04/30/2014CN103755669A Mailuoning hydrazone and preparation method and application thereof
04/30/2014CN103755643A Rosuvastatin calcium I crystal form
04/30/2014CN103751804A Application of interferon regulatory factor 4 (IRF4) gene in coronary atherosclerotic heart disease
04/30/2014CN103751803A Interferon regulatory factor 9 (IRF9) and application of inhibitor thereof in cerebral apoplexy
04/30/2014CN103751783A Function of IRF1 in aortic constriction disease and application of inhibitor thereof
04/30/2014CN103751781A Composition for preventing recurrence of stroke
04/30/2014CN103751765A Application of recombined ganoderma lucidum immunoregulation protein (rLZ-8) to preparation of medicine for treating tissue fibrosis
04/30/2014CN103751763A Methods for the prevention or treatment of vessel occlusion injury
04/30/2014CN103751761A Traditional Chinese medicine preparation for treating diabetes and preparation method
04/30/2014CN103751737A Drug for treating heart disease
04/30/2014CN103751717A Pharmaceutical composition for treating haemorrhoids
04/30/2014CN103751710A Traditional Chinese medicine composition for treating varicocele infertility and preparation method thereof
04/30/2014CN103751708A Traditional Chinese medicine external preparation for treating varix of lower limb and preparation method thereof
04/30/2014CN103751690A Traditional Chinese medicine decoction for treating angina and preparation method thereof
04/30/2014CN103751683A Pulse invigorating and kidney-replenishing Chinese medicinal preparation containing Codonopsis pilosula and safflower
04/30/2014CN103751681A Traditional Chinese medicine components for dredging channel, traditional Chinese medicine composition and preparation method thereof
04/30/2014CN103751680A Wind-calming and convulsion-relieving traditional Chinese medicine components, traditional Chinese medicine composition and preparation method thereof
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 1595